Evidence map›Paper›PMID 42421225›Full record

ArticleAmerican journal of respiratory and critical care medicine2026

Eosinophil-derived breath biomarkers and response to anti-IL-5/5R biologics in severe asthma.

Thibault Massenet, Pierre-Hugues Stefanuto, Rosa Peltrini, Rebecca Cordell, Hnin Aung, Eleanor Quek, Shahd Abuhelal, Matthew Richardson, Christopher Brightling, Paul Monks and 5 more

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Thibault MassenetOrganic and Biological Analytical Chemistry Group (OBiAChem), MolSys Research Unit, University of Liège, Liège, Belgium.
Pierre-Hugues StefanutoOrganic and Biological Analytical Chemistry Group (OBiAChem), MolSys Research Unit, University of Liège, Liège, Belgium.ORCID 0000-0002-1224-8869
Rosa PeltriniDepartment of Respiratory Sciences, University of Leicester, Leicester, United Kingdom.
Rebecca CordellDepartment of Chemistry, University of Leicester, Leicester, United Kingdom.
Hnin AungDepartment of Respiratory Sciences, University of Leicester, Leicester, United Kingdom.
Eleanor QuekNational Heart and Lung Institute (NHLI), Imperial College, London, United Kingdom.
Shahd AbuhelalNational Heart and Lung Institute (NHLI), Imperial College, London, United Kingdom.
Matthew RichardsonDepartment of Respiratory Sciences, University of Leicester, Leicester, United Kingdom.
Christopher BrightlingDepartment of Respiratory Sciences, University of Leicester, Leicester, United Kingdom.
Paul MonksDepartment of Chemistry, University of Leicester, Leicester, United Kingdom.
Neil GreeningDepartment of Respiratory Sciences, University of Leicester, Leicester, United Kingdom.
Michael WildeFaculty of Science and Engineering, University of Plymouth, Plymouth, United Kingdom.
Agnieszka SmolinskaDepartment of Pharmacology and Toxicology, Maastricht University, the Netherlands.
Florence SchleichRespiratory Medicine, University Hospital of Liège, GIGA I3 Research Group, Exercise Physiology Lab, Department of Physical Activity and Rehabilitation Sciences, University of Liège, Liège, Belgium.
Salman SiddiquiNational Heart and Lung Institute (NHLI), Imperial College, London, United Kingdom.

Funding

AstraZenecaBRCFondation Léon FrédéricqGlaxoSmithKlineMRCNIHR
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42421225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.